Literature DB >> 26073511

Layers of DUB regulation.

Danny D Sahtoe1, Titia K Sixma2.   

Abstract

Proteolytic enzymes, such as (iso-)peptidases, are potentially hazardous for cells. To neutralize their potential danger, tight control of their activities has evolved. Deubiquitylating enzymes (DUBs) are isopeptidases involved in eukaryotic ubiquitylation. They reverse ubiquitin signals by hydrolyzing ubiquitin adducts, giving them control over all aspects of ubiquitin biology. The importance of DUB function is underscored by their frequent deregulation in human disease, making these enzymes potential drug targets. Here, we review the different layers of DUB enzyme regulation. We discuss how post-translational modification (PTM), regulatory domains within DUBs, and incorporation of DUBs into macromolecular complexes contribute to their activity. We conclude that most DUBs are likely to use a combination of these basic regulatory mechanisms.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  allosteric; deubiquitinating enzyme; isopeptidase; mechanism; regulation; ubiquitin

Mesh:

Substances:

Year:  2015        PMID: 26073511     DOI: 10.1016/j.tibs.2015.05.002

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  61 in total

Review 1.  Ubiquitin, the centrosome, and chromosome segregation.

Authors:  Ying Zhang; Paul J Galardy
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

Review 2.  Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint.

Authors:  Key-Hwan Lim; Myoung-Hyun Song; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2016-01-13       Impact factor: 9.261

Review 3.  Deubiquitylating enzymes in neuronal health and disease.

Authors:  Fatima Amer-Sarsour; Alina Kordonsky; Yevgeny Berdichevsky; Gali Prag; Avraham Ashkenazi
Journal:  Cell Death Dis       Date:  2021-01-22       Impact factor: 8.469

4.  The deubiquitinase ubiquitin-specific protease 20 is a positive modulator of myocardial β1-adrenergic receptor expression and signaling.

Authors:  Samuel Mon-Wei Yu; Pierre-Yves Jean-Charles; Dennis M Abraham; Suneet Kaur; Clarice Gareri; Lan Mao; Howard A Rockman; Sudha K Shenoy
Journal:  J Biol Chem       Date:  2018-12-11       Impact factor: 5.157

5.  Modulation of conformational equilibrium by phosphorylation underlies the activation of deubiquitinase A.

Authors:  Ashish Kabra; Efsita Rumpa; Ying Li
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

Review 6.  Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.

Authors:  Yu Fujita; Roberto Tinoco; Yan Li; Daniela Senft; Ze'ev A Ronai
Journal:  Trends Mol Med       Date:  2019-03-18       Impact factor: 11.951

7.  Backbone 1H, 13C, and 15N resonance assignments of deubiquitinase A in non-phosphorylated and phosphorylated forms.

Authors:  Ashish Kabra; Catherine A Benson; Ying Li
Journal:  Biomol NMR Assign       Date:  2018-09-19       Impact factor: 0.746

8.  Dissenting degradation: Deubiquitinases in cell cycle and cancer.

Authors:  Thomas Bonacci; Michael J Emanuele
Journal:  Semin Cancer Biol       Date:  2020-03-20       Impact factor: 15.707

9.  USP13 controls the stability of Aurora B impacting progression through the cell cycle.

Authors:  Mara Esposito; H Begum Akman; Philippe Giron; M Angeles Ceregido; Rogier Schepers; Luis C Ramos Paez; Esther La Monaca; Jacques De Greve; Olivier Coux; Carl De Trez; Catherine Lindon; Gustavo J Gutierrez
Journal:  Oncogene       Date:  2020-08-08       Impact factor: 9.867

Review 10.  Targeting Pink1-Parkin-mediated mitophagy for treating liver injury.

Authors:  Jessica A Williams; Wen-Xing Ding
Journal:  Pharmacol Res       Date:  2015-10-24       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.